Canada’s research strength is world-class—now we need to all pull in the same direction
Our innovation system remains fragmented. Partnerships between universities, industry and government are often too ad hoc, funding cycles are short, and incentives are often misaligned.
Canada could have access to more than 10,000 doctors if licensing were less complicated, House Health Committee hears
The House Health Committee is looking into the links between immigration and health human resources shortages. But Liberal MP Mark Powlowski says the Conservatives’ language on this ‘ticks’ him off as it suggests the problem in health care is a result of too many immigrants, which ‘is clearly wrong.’
Turning innovation into impact: Canada’s biotech advantage
Canada continues to struggle at turning research strength into economic growth. For a country with world-class science, this gap is more than a statistic, it’s a signal of both risk, and opportunity.
‘Cutting red tape,’ mental health and primary care on the health docket this fall
Amid the Liberals’ focus on building a stronger economy, Health Minister Marjorie Michel’s office says that faster access to new medicines and supporting researchers are priorities.
Canada at risk of collateral damage in U.S. drug pricing war
A proactive and co-ordinated strategy from the government is essential to safeguard both access and affordability to medicines for the long term.
U.S. tariffs on pharmaceuticals could complicate an already complex supply chain
Drug companies could begin questioning whether to manufacture drugs or conduct clinical trials in Canada, says Life Sciences Ontario CEO.
A different ‘philosophy’ steers new drug pricing guidelines, says top PMPRB bureaucrat after contentious path to rule changes
Guideline changes became necessary after Justin Trudeau’s government chose to amend the Patented Medicines Regulations, a process beset with legal challenges and many delays.
Canada’s next top doctor must be a ‘focal point’ for public health amid changes in the U.S., concerns about next pandemic
Dr. Theresa Tam has left the job of chief public health officer after eight years. Her successor will have to contend with a change in the U.S.’ public health approach, vaccine hesitancy among Canadians and the need to always be ready for the next global outbreak.
From momentum to leadership: securing Canada’s biotech future
To lead in this space, Canada needs a globally competitive investment climate, and a best-in-class regulatory system.
Biotech
